Search Results 121-130 of 14746 for anti-TNF drugs

1. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary ...

2. Publications - Laura E. Raffals, M.D. - Mayo Clinic

   Anti-TNF biologic therapy does not increase postoperative morbidity in pediatric Crohn's patients. J Pediatr Surg. 2019 Oct; 54 (10):2162-2165 Epub 2019 Jan ...

3. Chronic pain: Medication decisions - Mayo Clinic

   Nonsteroidal anti-inflammatory drugs, known as NSAIDs · Acetaminophen · COX-2 inhibitors · Antidepressants and anti-seizure medications · Opioids · Pain medications ...

4. Prednisone and other corticosteroids: Balance the risks and benefits - Mayo Clinic

   Corticosteroid medicines include cortisone, hydrocortisone and prednisone. They are useful in treating rashes, inflammatory bowel disease, asthma and other ...

5. A Phase 2 Study of Anti-PD-L1 Antibody Atezolizumab in Alveolar Soft Part Sarcoma - Mayo Clinic

   ... [anti-TNF] agents) within 2 weeks prior to cycle 1, day 1. Patients who have received acute, low dose, systemic immunosuppressant medications (e.g., a one ...

6. Budesonide (Oral Route) Description and Brand Names - Mayo Clinic

   Description and Brand Names. Drug information provided by: Merative, Micromedex®. US Brand Name. Entocort EC; Eohilia; Ortikos; Uceris ...

7. Updates in interstitial lung disease: Current facets of anti-fibrotic therapy - Mayo Clinic

   Teng Moua, M.D., discusses recent clinical trials and current research into the treatment of idiopathic pulmonary fibrosis (IPF) and non-IPF-progressive ...

8. A Study to Evaluate the Effectiveness and Safety of MEDI2070 in Subjects with Active Moderate to Severe Crohn's Disease - Mayo Clinic

   Prior treatment failure or intolerance with at least one Anti-Tumor Necrosis-Factor-Alpha Therapy (anti-TNF α) agent; Effective contraception from screening ...

9. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

10. Research establishes strong association between family history and increased risk of colorectal cancer in patients with inflammatory bowel diseases - Mayo Clinic

    Examining clinical and genetic factors that impact response to anti-TNF agents in patients with IBD · Video. Chromoendoscopy for inflammatory bowel disease. MAC ...